New Instant Inoculator™ QC Microorganisms Eliminate Prep Work and Simplify Microbiology Control Testing with One-Step Method Kumar Jeetendra | November 9, 2021 2 November 2021 – Stratix Labs has unveiled Instant Inoculator™ QC microorganisms, a novel ready-to-use product that delivers reference microorganisms to solid media with a simple one-step method. Each device comes individually sealed with authentic reference microorganisms coated and preserved on the applicator region. Using a patent-pending technology, the Instant Inoculator™ directly transfers isolated colonies …
Stewardship, biomarkers, and advanced diagnostics to manage sepsis and antimicrobial resistance Kumar Jeetendra | December 20, 2021 Antimicrobial resistance (AMR) is a growing global problem and because the management of COVID-19 is increasingly becoming dependent on pharmacological interventions, there is greater risk for accelerating the evolution and spread of antimicrobial resistance. According to the WHO, AMR is the largest global health threat in the 21st century that requires urgent measures. Common infections …
SMART Researchers Pioneer Novel Way to Detect Microbial Contamination in Cell Cultures Kumar Jeetendra | June 20, 2022 Singapore, 20 June 2022 –Researchers from the Critical Analytics For Manufacturing Personalized-Medicine (CAMP) Interdisciplinary Research Group (IRG) at Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, have developed a new method of detecting adventitious microbial contamination in mesenchymal stromal cell (MSC) cultures, ensuring the rapid and accurate testing of cell therapy …
TM Media awarded by Economic Times “Economic Times Most Influential Leaders.” Kumar Jeetendra | August 3, 2022 Recently, TM Media (Titan Biotech Ltd) was presented with the ‘Economic Times Most Influential Leaders Award’ by Economic Times. The achievements of these leaders have also been chronicled in ET Now TV Episode called ET Most Influential Leaders and showcase their inspiring work in their respective sectors in a spectacular style. These leaders are also …
HiGenoMB®-HiMedia Receives CE-IVD Approval for Hi-PCR®COVID-FLU Multiplex Probe PCR Kit (MBPCR262) Kumar Jeetendra | August 6, 2022 HiGenoMB® Molecular Biology Division of HiMedia Laboratories Pvt. Ltd. the pioneers in Indian BioSciences manufacturing segment adds another feather in the cap with their newly CE/IVD approved Hi-PCR®COVID-FLU Multiplex Probe PCR Kit (MBPCR262). Molecular Diagnostics based on real-time PCR is increasingly becoming the gold standard post COVID-19. Hi-PCR® COVID-FLU Multiplex Probe PCR Kit, is a …
Optimized Lentiviral Vectors to Speed Up Your Research Kumar Jeetendra | August 25, 2022 AMSBIO offers a range of lentivirus production services to provide tailor-made products to support your research. Lentiviral vectors are a valuable tool for delivering target genes into most types of dividing and non-dividing mammalian cells in vitro and in vivo. Typically, production of custom lentiviral vectors is a laborious and challenging process, especially when high-titer …
Room Temperature RNA Stabilization for Tissue Samples Kumar Jeetendra | November 3, 2022 AMSBIO announce RNAdvantage – the first product in a new range of stabilization solutions that provide robust protection for your RNA samples at ambient temperature. Designed to protect and preserve RNA from most tissues, cultured cells, bacteria, and yeast for up to 14-days, RNAdvantage eliminates the traditional costs of flash freezing samples dry-ice shipping and …
LifeCell and HaystackAnalytics enter into a strategic collaboration to Scale TB Whole Genome Sequencing Pan India Kumar Jeetendra | December 7, 2022 National, December 7th, 2022: LifeCell, one of India’s leading comprehensive healthcare solutions providers today announced the launch of a revolutionary genetic test – ΩTB® (pronounced as Omega TB) in partnership with HaystackAnalytics, a genomics based health-tech startup. The collaboration marks LifeCell’s foray into the genetic testing industry for TB patients. The whole genome-sequencing test, designed …
